Christopher Ung is the Chief Business Officer at CellCarta. Christopher Ung attended the University of California, Los Angeles.
Christopher Ung is a highly experienced professional with 33.8 years of work experience in the pharmaceutical industry. He has a diverse skill set that includes oncology, biotechnology, clinical trials, commercialization, and clinical research. Currently, he serves as the Chief Business Officer at CellCarta, a leading pharmaceutical company. With a background in biomarker development and cross-functional team leadership, Christopher has successfully led various departments and contributed to the growth and success of the organizations he has worked for. He is based in Naperville, Illinois, United States.
STC Biologics Inc. Is a biotech company located in Cambridge MA specializing in the development of biologic drugs with a focus on biosimilars. STC scientist are experts in analytics driven process development. Our strategy is to partner with various pharmaceutical and biotechnology companies to expedite drug development and to solve all hurdles in analytical development and process development. Specialties drug development from target selection to IND/CTA filling and BLA/MAA, biologics process development, analytics driven process development, biosimilar development
Durham,North Carolina,United States
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 86,000 employees, IQVIA conducts operations in more than 100 countries. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
Glostrup,Capital Region Of Denmark,Denmark
Dako is owned by Agilent Technologies. Hospitals and research laboratories worldwide use Agilent's Dako brand of pathology solutions, including reagents, instruments, software and expertise, to make accurate tissue-based diagnoses and determine the most effective treatment for cancer patients. www.dako.com
Cross Functional Team Leadership
We found 2 Christopher Ung's email addresses
Christopher Ung works for CellCarta
Christopher Ung's role in CellCarta is Chief Business Officer
Christopher Ung's latest job experience is Chief Business Officer at CellCarta
Christopher Ung's latest education in University of California, Los Angeles